Clinical Trial

The Effect of Algae Oil Supplements on Functional Immune Response and Bioavailability of Lipids in Blood, a Pilot Study

Study acronym: ALG
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 25, 2025 (before its estimated November 14, 2025 completion). Its status may not reflect the trial's current state.
Summary
In this explorative study we will investigate whether two sustainable oil supplements yield equivalent results to fish oil supplements in terms of postprandial immune response, among elderly adults, after standardization of the quantity of DHA among the oils. Results on the bioavailability of DHA from different oil supplements will help determine whether differences in DHA bioavailability lead to differences in immune function. Additionally, we will investigate postprandial inflammatory markers. The outcomes of this exploratorive study will provide insight into the variation between individuals and potential effect sizes, and will aim to conduct more targeted follow-up studies on the effects of algae oils on immune function.
Trial Details
NCT Number NCT07086573
Lead Sponsor Maartje van den Belt
Collaborators: Nutricia Research, Fermentalg, Microalgas Oleas de México, S.A. de C.V., Utrecht University
Conditions Functional Immune Response, Postprandial Bioavailability DHA, Fatty Acid Metabolism
Enrollment 12 participants
Start Date 2025-09-22
Primary Completion 2025-11-14 (estimated)
Study Completion 2025-11-14 (estimated)
Updated on ClinicalTrials.gov 2025-07-25